Ginsenoside Rh2(S) induces differentiation and mineralization of MC3T3-E1 cells through activation of the PKD/AMPK signaling pathways

International Journal of Molecular Medicine

Volumn 28, Issue 5, 2011, Pages 753-759

  Kim, Do Yeon ^a   Park, Ki Ho ^a   Jung, Mi Song ^a   Huang, Bo ^a   Yuan, Hai Dan ^a   Quan, Hai Yan ^a   Chung, Sung Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

AMP activated protein kinase; Ginsenoside Rh2(S); MC3T3 E1; Osteoblastic differentiation; Protein kinase D

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; ALKALINE PHOSPHATASE; GINSENOSIDE RH 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PROTEIN KINASE D; VIDARABINE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION (PARAMETERS); EMBRYO; GENE; MINERALIZATION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; GINSENOSIDES; MICE; OSTEOBLASTS; PROTEIN KINASE C; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 80053116380     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.750     Document Type: Article

References (26)

1. Olsen BR, Reginato AM and Wang W: Bone development. Annu Rev Cell Dev Biol 16: 191-220, 2000.
2. Shin HY, Jeong HJ, An HJ, Hong SH, Um JY, Shin TY, Kwon SJ, Jee SY, Seo BI, Shin SS, Yang DC and Kim HM: The effect of Panax ginseng on forced immobility time and immune function in mice. Indian J Med Res 124: 199-206, 2006.
3. Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H and Zhang R: In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol 59: 589-601, 2007.
4. Polan ML, Hochberg RB, Trant AS and Wuh HC: Estrogen bioassay of ginseng extract and ArginMax, a nutritional supplement for the enhancement of female sexual function. J Womens Health (Larchmt.) 13: 427-430, 2004.
5. Hwang JT, Kim SH, Lee MS, Kim SH, Yang HJ, Kim MJ, Kim HS, Ha J, Kim MS and Kwon DY: Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte. Biochem Biophys Res Commun 64: 1002-1008, 2007.
6. Liu J, Shiono J, Shimizu, Yu H, Zhang C, Jin F and Kondo R: 20(R)-ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity. Bioorg Med Chem Lett 19: 3320-3323, 2009.
7. Riggs B and Melton LJ: The prevention and treatment of osteoporosis. N Engl J Med 327: 620-627, 1992.
8. McCarthy TL, Centrella M and Cannalis E: Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 124: 301-309, 1989.
9. Nada M and Camilliere JJ: In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124: 2991-2994, 1989.
10. Lin L, Dai SD and Fan GY: Glucocorticoid-induced differentiation of primary cultured bone marrow mesenchymal cells into adipocytes is antagonized by exogenous Runx2. APMIS 118: 595-605, 2010.
11. Ducy P, Schinke T and Karsenty G: The osteoblast: a sophisticated fibroblast under central surveillance. Science 289: 1501-1504, 2000.
12. Attele As, Wu JA and Yuan CA: Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 58: 1685-1693, 1999.
13. Nakata H, Kikuchi Y, Toden T, Hirata J, Kita T, Ishii K, Kudoh K, Nagata I and Shinomiya N: Inhibitory effects of ginsenoside Rh-2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res 89: 733-740, 1998.
14. Popovich DG and Kitts DD: Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells. J Biochem Mol Toxicol 18: 143-149, 2004.
15. Lee WK, Kao ST, Liu IM and Cheng JT: Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats. Horm Metab Res 39: 347-354, 2007.
16. Lee WK, Kao ST, Liu IM and Cheng JT: Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats. Clin Exp Pharmacol Physiol 33: 27-32, 2006.
17. Bae Ea, Han MJ and Kim EJ: Transformation of Ginseng saponins to Ginsenoside Rh2 by and acids and human intestinal bacteria and biological activities of their transformants. Arch Pharm Res 27: 61-67, 2004.
18. Gschwendt M, Dieterich S, Rennecke H, Kittstein W, Mueller HJ and Fohannes FJ: Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett 392: 77-80, 1996.
19. Cheung WM, Ng WW and Kung AW: Dimethyl sulfoxide as an inducer of differentiation in preosteoblast MC3T3-E1 cells. FEBS Lett 580: 121-126, 2006.
20. Lemonnier J, Ghayor, Guicheux J and Caverzasio J: Protein kinase C-independent activation of protein kinase D is involved in BMP-2-induced activation of stress mitogen-activated protein kinses JNK and p38 and osteoblastic cell differentiation. J Biol Chem 279: 259-264, 2004.
21. Lage R, Dieguez C, Vidal-Puig A and Lopez M: AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol Med 14: 539-549, 2004.
22. Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M and Sugimoto T: Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol 8: 51-62, 2007.
23. Fryer LGD, Parbu-Patel A and Carling D: The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277: 25226-25232, 2002.
24. Cortizo AM, Sedlinski C, McCarthy AD, Blanco A and Schurman L: Osteogenic actions of the anti- diabetic drug metformin on osteoblasts in culture. Eur J Pharmacol 536: 38-46, 2006.
25. Motyl KJ, McCabe LR and Schwarz AV: Bone and glucose metabolism: a two-way street. Arch Biochem Biophys 503: 2-10, 2010.
26. Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho Ra, Teti A, Ducy P and Karsenty G: Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Eur J Appl Physiol 110: 6435-6433, 2010.